Health Care & Life Sciences » Pharmaceuticals | Catalyst Pharmaceuticals Inc.

Catalyst Pharmaceuticals Inc. | Balance Sheet

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
23,710.60
39,275.10
58,396.40
40,405.80
84,013.40
53,481.60
Total Accounts Receivable
-
3,500.00
-
-
-
-
Other Current Assets
1,609.40
1,052.70
1,504.70
1,047.90
1,173.70
1,649.80
Total Current Assets
25,320.00
43,827.80
59,901.10
41,453.80
85,187.20
55,187.40
Net Property, Plant & Equipment
40.60
71.40
191.50
244.20
191.40
245.40
Other Assets
8.90
8.90
8.90
8.90
8.90
8.90
Total Assets
25,369.60
43,908.10
60,101.60
41,706.90
85,387.40
60,450
Accounts Payable
850.80
-
-
-
-
Other Current Liabilities
1,288.80
5,855.00
3,440.60
2,094.50
4,266.20
Total Current Liabilities
2,139.60
5,855.00
3,440.60
2,094.50
4,266.20
Other Liabilities
1,838.70
2,810.70
1,184.70
303.40
157.50
Total Liabilities
3,978.30
8,665.80
4,625.30
2,397.90
4,423.60
Common Equity (Total)
21,391.30
35,242.30
55,476.30
39,308.90
80,963.80
Total Shareholders' Equity
21,391.30
35,242.30
55,476.30
39,308.90
80,963.80
Total Equity
21,391.30
35,242.30
55,476.30
39,308.90
80,963.80
Liabilities & Shareholders' Equity
25,369.60
43,908.10
60,101.60
41,706.90
85,387.40

About Catalyst Pharmaceuticals

View Profile
Address
355 Alhambra Circle
Coral Gables Florida 33134
United States
Employees -
Website http://www.catalystpharma.com
Updated 07/08/2019
Catalyst Pharmaceuticals, Inc. is a biopharmaceutical company. It focuses on development and commercialization of prescription drugs targeting rare (orphan) neuromuscular and neurological diseases, including Lambert-Eaton Myasthenic Syndrome (LEMS), infantile spasms, and Tourette's disorder. The company was founded by McEnany J.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.